2014, Number S1
<< Back Next >>
Rev Mex Anest 2014; 37 (S1)
Mechanisms of cell protection with α2-agonistas
Ibacache-Figueroa ME
Language: Spanish
References: 7
Page: 251-253
PDF size: 149.16 Kb.
Text Extraction
No abstract
REFERENCES
Bylund D. Pharmacological characteristics of alpha-2 adrenergic receptor subtypes. Ann N Y Acad Sci. 1995;763:1-7.
Berkowitz D, Price D, Bello E, Page S, Schwinn D. Localization of messenger RNA for three distinct alpha 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology. 1994;81:1235-1244.
Lorenz W, Lomasney J, Collins S, Regan J, Caron M, Lefkowitz R. Expression of three a2-adrenergic receptor subtypes in rat tissues: implications for a2 receptor classification. Mol Pharmacol. 1990;38:599-603.
Chalikonda SA. Alpha 2-adrenergic agonists and their role in the prevention of perioperative adverse cardiac events. AANA Journal. 2009;77:103-108.
Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature. 2002;415: 206-212.
Ibacache M, Sanchez G, Pedrozo Z, Galvez F, Humeres C, Echevarria G, et al. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochim Biophys Acta. 2012;1822:537-545.
Cai Y, Xu H, Yan J, Zhang L, Lu Y. Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. Mol Med Rep. 2014;9:1542-1550.
Full text